Good Review Principles Implementation Could Threaten Six-Month Priority Review Timeframe
This article was originally published in The Pink Sheet Daily
Executive Summary
OND Director Jenkins tells FDC/Windhover conference that newly-defined best practices are difficult to accomplish within six months and "nearly impossible" if the priority application must face an advisory panel.
You may also be interested in...
First-Cycle Approval Rate Already High; Can PDUFA V Actually Boost It?
FDA official says the rate of approving applications in the first review cycle may not increase much more, even as the new review model, intended to promote more first-cycle approvals, has yet to finish with its inaugural applications.
PDUFA Talks: FDA Floats “Information Sharing” Pause In New Review Model
FDA’s new proposed review model would break the process into four distinct phases and eliminate some extensions of the review deadline, yet the actual review cycle still likely would be lengthened.
PDUFA Talks: FDA Floats “Information Sharing” Pause In New Review Model
FDA’s new proposed review model would break the process into four distinct phases and eliminate some extensions of the review deadline, yet the actual review cycle still likely would be lengthened.